Wolverine Blend (BPC-157 / TB-500)
BPC-157 + TB-500 · Wolverine
The classic recovery pairing — BPC-157 and TB-500 in one vial for soft-tissue repair.
Class
BPC-157 + Thymosin Beta-4 fragment blend
Half-life
Mixed (BPC-157 short; TB-500 several hours)
Evidence
Animal models
Animal models
Evidence comes primarily from rodent or other animal studies. Translation to humans is unproven.
Overview
The 'Wolverine' blend combines the two most popular recovery peptides: BPC-157 (angiogenesis and broad tissue protection) and TB-500 (cell migration and repair). The rationale is that they act through complementary mechanisms, so pairing them may support healing more completely than either alone.
It carries exactly the same evidence caveat as its components: the healing effects are demonstrated in animals, not in completed human trials. It is popular precisely because both compounds are individually popular, but the combination has no human evidence of its own, and both are WADA-prohibited.
How it works
- BPC-157 promotes angiogenesis (VEGFR2) and cytoprotection in injured tissue.
- TB-500 regulates actin to promote migration of repair cells into damage.
- The two mechanisms are complementary — vascular ingrowth plus cellular repopulation.
What the research shows
Researched effects
- Accelerated soft-tissue, tendon, and muscle healing in animal models (per component)
- Anti-inflammatory effects
- Popular for injury recovery despite the absence of human trial data
Limitations & what it won't do
- No human trials of the blend or its components for musculoskeletal recovery.
- Both components are WADA-prohibited.
- Shared angiogenesis-related tumour caution.
Dosing protocols
These ranges reflect published trials and community protocols. They are reference information, not a prescription. Doses are per injection unless noted.
Combined recovery protocol (community)
250–500 mcg BPC + ~2 mg TB (per component)Dosing follows each component's schedule. See the BPC-157 and TB-500 profiles for detail.
Reconstitution & measuring your dose
Handling
- Typical vial sizes
- 10 · 20 mg
- Suggested BAC water
- 2 mL
- Storage
- Lyophilised powder refrigerated at 2–8 °C, protected from light.
- After reconstitution
- Reconstituted: approximately 30 days refrigerated.
Why 2 mL? A 10/10 mg blend vial (20 mg total) in 2 mL yields 10 mg/mL total. Because the two peptides are pre-mixed at a fixed ratio, you dose the combined solution — you cannot titrate them independently.
Dose calculator
Draw to
2.5units
= 0.025 mL · 100 mcg per unit
Concentration
10000 mcg/mL
Doses per vial
80
Side effects
Common
- Injection-site irritation
- Transient fatigue or head rush
- Generally reported as well tolerated
Serious / rare
- Unknown — no human safety data
- Theoretical angiogenesis/tumour concern
Contraindications & interactions
Do not use if you have
- Active cancer or current oncology treatment
Both components promote angiogenesis; contraindicated during active malignancy.
- Pregnant, breastfeeding, or trying to conceive
No pregnancy safety data.
Use caution if you have
- Past cancer diagnosis (in remission)
Obtain oncology clearance given the angiogenic mechanism.
What to monitor
- Injury response and function
- New or unusual symptoms given the absence of human safety data
Commonly combined with
References
- See component profilesBPC-157 and TB-500 — full mechanism and evidence
Research & educational information only — not medical advice.
You must be 18 or older to use this site. The peptides described are presented as research chemicals intended for research purposes only. Most are not approved by the FDA for human use. Dosing ranges reflect what has appeared in the scientific literature or community protocols and are not prescriptions. Nothing here replaces evaluation by a licensed physician who knows your full medical history.
Want to know if Wolverine Blend (BPC-157 / TB-500) fits your goals and history?
The assessment cross-checks your medical history and medications against this and every other compound before it recommends anything.
Start the assessment